Principal Financial Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.87M Buy
5,649
+2,151
+61% +$732K ﹤0.01% 1839
2025
Q4
$1.39M Sell
3,498
-1,922
-35% -$851K ﹤0.01% 1900
2025
Q3
$2.47M Sell
5,420
-45,114
-89% -$18.4M ﹤0.01% 1776
2025
Q2
$16.5M Buy
50,534
+15,833
+46% +$4.38M 0.01% 955
2025
Q1
$9.37M Buy
34,701
+24,323
+234% +$6.25M 0.01% 1298
2024
Q4
$2.44M Sell
10,378
-230
-2% -$60.5K ﹤0.01% 1769
2024
Q3
$2.92M Sell
10,608
-3,581
-25% -$932K ﹤0.01% 1712
2024
Q2
$3.45M Sell
14,189
-5,167
-27% -$816K ﹤0.01% 1664
2024
Q1
$2.89M Sell
19,356
-273
-1% -$45.5K ﹤0.01% 1717
2023
Q4
$3.76M Sell
19,629
-2,876
-13% -$490K ﹤0.01% 1650
2023
Q3
$3.99M Buy
22,505
+843
+4% +$161K ﹤0.01% 1608
2023
Q2
$4.11M Buy
21,662
+678
+3% +$134K ﹤0.01% 1605
2023
Q1
$4.2M Sell
20,984
-2,979
-12% -$626K ﹤0.01% 1591
2022
Q4
$5.69M Sell
23,963
-2,482
-9% -$529K ﹤0.01% 1490
2022
Q3
$5.29M Sell
26,445
-5,083
-16% -$970K ﹤0.01% 1472
2022
Q2
$4.6M Buy
31,528
+3,063
+11% +$435K ﹤0.01% 1581
2022
Q1
$4.65M Sell
28,465
-1,557
-5% -$237K ﹤0.01% 1685
2021
Q4
$5.09M Sell
30,022
-8,618
-22% -$1.6M ﹤0.01% 1657
2021
Q3
$7.3M Sell
38,640
-4,295
-10% -$806K ﹤0.01% 1544
2021
Q2
$7.28M Buy
42,935
+2,855
+7% +$418K ﹤0.01% 1573
2021
Q1
$5.66M Buy
40,080
+2,014
+5% +$303K ﹤0.01% 1626
2020
Q4
$4.95M Buy
38,066
+4,901
+15% +$654K ﹤0.01% 1565
2020
Q3
$4.83M Sell
33,165
-3,026
-8% -$430K ﹤0.01% 1460
2020
Q2
$5.36M Buy
36,191
+7,274
+25% +$981K ﹤0.01% 1391
2020
Q1
$3.15M Buy
28,917
+1,478
+5% +$171K ﹤0.01% 1458
2019
Q4
$3.16M Sell
27,439
-93
-0.3% -$9.27K ﹤0.01% 1645
2019
Q3
$2.21M Sell
27,532
-1,035
-4% -$81.9K ﹤0.01% 1703
2019
Q2
$2.07M Buy
28,567
+2,934
+11% +$225K ﹤0.01% 1715
2019
Q1
$2.4M Buy
25,633
+1,788
+7% +$150K ﹤0.01% 1709
2018
Q4
$1.74M Sell
23,845
-1,337
-5% -$103K ﹤0.01% 1737
2018
Q3
$2.2M Buy
25,182
+893
+4% +$89.8K ﹤0.01% 1749
2018
Q2
$2.39M Sell
24,289
-236
-1% -$23.4K ﹤0.01% 1736
2018
Q1
$2.92M Buy
24,525
+1,263
+5% +$163K ﹤0.01% 1694
2017
Q4
$2.96M Buy
23,262
+10,063
+76% +$1.26M ﹤0.01% 1700
2017
Q3
$1.55M Sell
13,199
-2,057
-13% -$176K ﹤0.01% 1770
2017
Q2
$1.22M Buy
15,256
+2,928
+24% +$187K ﹤0.01% 1815
2017
Q1
$632K Sell
12,328
-523
-4% -$24.2K ﹤0.01% 1886
2016
Q4
$481K Sell
12,851
-2,266
-15% -$94.9K ﹤0.01% 1928
2016
Q3
$1.02M Sell
15,117
-35
-0.2% -$2.47K ﹤0.01% 1763
2016
Q2
$841K Buy
15,152
+1,761
+13% +$111K ﹤0.01% 1780
2016
Q1
$841K Sell
13,391
-77
-0.6% -$5.12K ﹤0.01% 1757
2015
Q4
$1.27M Buy
13,468
+21
+0.2% +$1.95K ﹤0.01% 1720
2015
Q3
$1.08M Buy
13,447
+5,998
+81% +$666K ﹤0.01% 1757
2015
Q2
$893K Buy
7,449
+2,952
+66% +$353K ﹤0.01% 1801
2015
Q1
$470K Sell
4,497
-721
-14% -$73.1K ﹤0.01% 1848
2014
Q4
$506K Buy
+5,218
New +$483K ﹤0.01% 1878
2014
Q3
Sell
-30,604
Closed -$1.93M 2206
2014
Q2
$1.93M Sell
30,604
-45,820
-60% -$2.72M ﹤0.01% 1688
2014
Q1
$5.13M Sell
76,424
-176
-0.2% -$13.6K 0.01% 1348
2013
Q4
$4.93M Buy
76,600
+4,252
+6% +$254K 0.01% 1355
2013
Q3
$4.63M Buy
72,348
+55,353
+326% +$2.76M 0.01% 1320
2013
Q2
$527K Buy
+16,995
New +$452K ﹤0.01% 1824

Other funds holding ALNY